Mouse Model of Neurodegeneration: Atrophy of Basal Forebrain Cholinergic Neurons in Trisomy 16 Transplants

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1992 Feb 15

PMID 1741393

Citations 16

Authors

D M Holtzman

Y W Li

S J DeArmond

M P McKinley

F H Gage

C J Epstein

W C Mobley

Affiliations

Soon will be listed here.

Abstract

Vulnerability of specific brain regions and neuronal populations is a characteristic feature of Alzheimer disease and Down syndrome. Cholinergic neurons of the basal forebrain degenerate in both disorders. The basis for neuronal degeneration is unknown. Mouse trisomy 16 (Ts 16) is an animal model of Down syndrome. We sought an experimental system in which the survival and development of Ts 16 basal forebrain cholinergic neurons could be examined beyond the fetal period. As Ts 16 mice do not survive birth, we transplanted fetal Ts 16 and control basal forebrain into the hippocampus of young adult mice. Transplanted neurons survived and grew neurites in all grafts. Over time, we observed selective atrophy of cholinergic neurons in Ts 16 grafts. Denervation of the hippocampus produced a significant increase in the size of Ts 16 cholinergic neurons. This suggests that hippocampal-derived neurotrophic factors acted to prevent degeneration. beta/A4-amyloid-containing plaques were not seen. Ts 16 provides a model of spontaneous, genetically determined neurodegeneration that may be used to understand better the molecular pathogenesis of neuronal dysfunction in Alzheimer disease and Down syndrome.

Citing Articles

Single-nucleus analysis reveals dysregulated oxidative phosphorylation in Down syndrome basal forebrain at birth.

West N, Arachchilage K, Knaack S, Hosseini M, Risgaard R, MacGregor S bioRxiv. 2025; .

PMID: 39975363 PMC: 11839037. DOI: 10.1101/2025.02.05.636750.

Nerve Growth Factor Compromise in Down Syndrome.

Do Carmo S, Kannel B, Cuello A Front Aging Neurosci. 2021; 13:719507.

PMID: 34434101 PMC: 8381049. DOI: 10.3389/fnagi.2021.719507.

Cystatin C prevents neuronal loss and behavioral deficits via the endosomal pathway in a mouse model of down syndrome.

Kaur G, Gauthier S, Perez-Gonzalez R, Pawlik M, Singh A, Cosby B Neurobiol Dis. 2018; 120:165-173.

PMID: 30176349 PMC: 6309243. DOI: 10.1016/j.nbd.2018.08.025.

Mouse-based genetic modeling and analysis of Down syndrome.

Xing Z, Li Y, Pao A, Bennett A, Tycko B, Mobley W Br Med Bull. 2016; 120(1):111-122.

PMID: 27789459 PMC: 5146682. DOI: 10.1093/bmb/ldw040.

Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.

Strupp B, Powers B, Velazquez R, Ash J, Kelley C, Alldred M Curr Alzheimer Res. 2015; 13(1):97-106.

PMID: 26391046 PMC: 4733524. DOI: 10.2174/1567205012666150921100311.

References

Gage F, Bjorklund A . Enhanced graft survival in the hippocampus following selective denervation. Neuroscience. 1986; 17(1):89-98. DOI: 10.1016/0306-4522(86)90227-7. View

Maisonpierre P, Belluscio L, Friedman B, Alderson R, Wiegand S, Furth M . NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression. Neuron. 1990; 5(4):501-9. DOI: 10.1016/0896-6273(90)90089-x. View

Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R . Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med. 1989; 320(22):1446-52. DOI: 10.1056/NEJM198906013202203. View

Coyle J, Reeves R, Gearhart J . Down syndrome, Alzheimer's disease and the trisomy 16 mouse. Trends Neurosci. 1988; 11(9):390-4. DOI: 10.1016/0166-2236(88)90075-6. View

Tanzi R, St George-Hyslop P, Gusella J . Molecular genetic approaches to Alzheimer's disease. Trends Neurosci. 1989; 12(4):152-8. DOI: 10.1016/0166-2236(89)90055-6. View

Wisniewski K, Wisniewski H, Wen G . Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol. 1985; 17(3):278-82. DOI: 10.1002/ana.410170310. View

Katzman R . Alzheimer's disease. N Engl J Med. 1986; 314(15):964-73. DOI: 10.1056/NEJM198604103141506. View

Price D . New perspectives on Alzheimer's disease. Annu Rev Neurosci. 1986; 9:489-512. DOI: 10.1146/annurev.ne.09.030186.002421. View

Masters C, Simms G, Weinman N, Multhaup G, McDonald B, Beyreuther K . Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985; 82(12):4245-9. PMC: 397973. DOI: 10.1073/pnas.82.12.4245. View

10.

Casanova M, Walker L, Whitehouse P, Price D . Abnormalities of the nucleus basalis in Down's syndrome. Ann Neurol. 1985; 18(3):310-3. DOI: 10.1002/ana.410180306. View

11.

Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P . Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 1989; 341(6238):149-52. DOI: 10.1038/341149a0. View

12.

Card J, Meade R, Davis L . Immunocytochemical localization of the precursor protein for beta-amyloid in the rat central nervous system. Neuron. 1988; 1(9):835-46. DOI: 10.1016/0896-6273(88)90131-6. View

13.

Zhou C, Raisman G, Morris R . Specific patterns of fibre outgrowth from transplants to host mice hippocampi, shown immunohistochemically by the use of allelic forms of Thy-1. Neuroscience. 1985; 16(4):819-33. DOI: 10.1016/0306-4522(85)90096-x. View

14.

Sweeney J, Hohmann C, Coyle J . Neurogenesis of the basal forebrain in euploid and trisomy 16 mice: an animal model for developmental disorders in Down syndrome. Neuroscience. 1989; 31(2):413-25. DOI: 10.1016/0306-4522(89)90384-9. View

15.

Siman R, Card J, Nelson R, Davis L . Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron. 1989; 3(3):275-85. DOI: 10.1016/0896-6273(89)90252-3. View

16.

Kitt C, Price D, Struble R, Cork L, Wainer B, Becher M . Evidence for cholinergic neurites in senile plaques. Science. 1984; 226(4681):1443-5. DOI: 10.1126/science.6505701. View

17.

Uylings H, Van Eden C, Hofman M . Morphometry of size/volume variables and comparison of their bivariate relations in the nervous system under different conditions. J Neurosci Methods. 1986; 18(1-2):19-37. DOI: 10.1016/0165-0270(86)90111-1. View

18.

Williams L, Varon S, Peterson G, Wictorin K, Fischer W, Bjorklund A . Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci U S A. 1986; 83(23):9231-5. PMC: 387109. DOI: 10.1073/pnas.83.23.9231. View

19.

Fischer W, Wictorin K, Bjorklund A, Williams L, Varon S, Gage F . Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 1987; 329(6134):65-8. DOI: 10.1038/329065a0. View

20.

Large T, Bodary S, Clegg D, Weskamp G, Otten U, Reichardt L . Nerve growth factor gene expression in the developing rat brain. Science. 1986; 234(4774):352-5. DOI: 10.1126/science.3764415. View